Back to News

Friedrich Miescher Institute (FMI)

The Friedrich Miescher Institute is a high-caliber research institute collaborating on scientific work relevant to GenSight Biologics’ pipeline and the evolution of its technology platforms.

Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France